Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Falanga

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
HLA|July 4, 2017
Identification of the new HLA-DRB1*14:186 allele in an Italian bone marrow donorF Zanchi, L Castellani, F Gualandris, et al.
Blood|April 1, 1988
A new procoagulant in acute leukemiaA Falanga, M G Alessio, M B Donati, et al.
British Journal of Haematology|May 1, 1996
All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4M Marchetti, A Falanga, S Giovanelli, et al.
American Journal of Hematology|November 1, 1992
Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndromeG Finazzi, P Bellavita, A Falanga, et al.
Thrombosis and Haemostasis|February 28, 1984
SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitorV Bertelé, A Falanga, M Tomasiak, et al.
Haemostasis|January 1, 1986
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?M B Donati, M C Roncaglioni, A Falanga, et al.
Thrombosis and Haemostasis|December 1, 1994
Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulationG Finazzi, A Falanga, M Galli, et al.
Science (New York, N.Y.)|April 29, 1983
Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma"V Bertelé, A Falanga, M Tomasiak, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemiaA Falanga, F A Ofosu, S Cortelazzo, et al.
Blood|June 1, 1984
Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase productsV Bertelé, A Falanga, M Tomasiak, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
HLA|July 4, 2017
Identification of the new HLA-DRB1*14:186 allele in an Italian bone marrow donorF Zanchi, L Castellani, F Gualandris, et al.
Blood|April 1, 1988
A new procoagulant in acute leukemiaA Falanga, M G Alessio, M B Donati, et al.
British Journal of Haematology|May 1, 1996
All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4M Marchetti, A Falanga, S Giovanelli, et al.
American Journal of Hematology|November 1, 1992
Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndromeG Finazzi, P Bellavita, A Falanga, et al.
Thrombosis and Haemostasis|February 28, 1984
SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitorV Bertelé, A Falanga, M Tomasiak, et al.
Haemostasis|January 1, 1986
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?M B Donati, M C Roncaglioni, A Falanga, et al.
Thrombosis and Haemostasis|December 1, 1994
Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulationG Finazzi, A Falanga, M Galli, et al.
Science (New York, N.Y.)|April 29, 1983
Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma"V Bertelé, A Falanga, M Tomasiak, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemiaA Falanga, F A Ofosu, S Cortelazzo, et al.
Blood|June 1, 1984
Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase productsV Bertelé, A Falanga, M Tomasiak, et al.
Pageof 9